The LikeMinds intellectual property portfolio consists of a number of trade secrets as well as a strong patent portfolio of issued, in development and pending patents.
LikeMinds Licensed Patentsand Applications– –
Issued U.S. patent (and foreign equivalents) # 8,084,018 covering the imaging protocol method to be used with [123I]-E-IACFT. U.S. expiration is 6/30/2030.
Pending U.S. and foreign patent application number PCT/US2008/81569 filed 10/29/08 covering the use of Altropane in the diagnosis of Lewy Body Dementia; U.S. expiration is estimated to be 2028.
Issued US patent 8,986,653 and foreign equivalents expiring 10/31/2028 covering the iodination method used to manufacture DaT2020, issued US patent 8,574,545 and foreign equivalents expiring 9/6/2030 covering high iodine concentration formulations and issued US patent 9,757,483 covering optimal purity of radioactive iodine applied to a precursor ligand.